Get Live Data

Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. BROKER RATINGS: Johnson Matthey and Meggitt receive upgrades

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: Johnson Matthey and Meggitt receive upgrades

Fri, 30th Apr 2021 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

----------

FTSE 100

----------

HSBC RAISES JOHNSON MATTHEY TO 'BUY' ('HOLD') - TARGET 3,750 (2,850) PENCE

----------

CITIGROUP RAISES WEIR GROUP PRICE TARGET TO 2,100 (1,900) PENCE - 'NEUTRAL'

----------

MORGAN STANLEY CUTS RECKITT BENCKISER PRICE TARGET TO 7,300 (7,900) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES RECKITT BENCKISER PRICE TARGET TO 10,400 (9,600) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES STANDARD CHARTERED PRICE TARGET TO 630 (550) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES STANDARD CHARTERED PRICE TARGET TO 730 (690) PENCE - 'BUY'

----------

BERENBERG RAISES NATWEST PRICE TARGET TO 230 (200) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS NATWEST PRICE TARGET TO 295 (300) PENCE - 'CONVICTION BUY LIST'

----------

MORGAN STANLEY RAISES NATWEST PRICE TARGET TO 250 (245) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES LLOYDS PRICE TARGET TO 55 (47) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES LLOYDS PRICE TARGET TO 54 (50) PENCE - 'OUTPERFORM'

----------

DEUTSCHE BANK RAISES GLAXOSMITHKLINE PRICE TARGET TO 1,200 (1,150) PENCE - 'SELL'

----------

DZ BANK CUTS FAIR VALUE FOR GLAXOSMITHKLINE TO 1,510 (1,550) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES FLUTTER PRICE TARGET TO 16,285 (15,485) PENCE - 'HOLD'

----------

JPMORGAN CUTS FLUTTER PRICE TARGET TO 15,970 (16,233) PENCE - 'NEUTRAL'

----------

HSBC RAISES LEGAL & GENERAL PRICE TARGET TO 330 (290) PENCE - 'BUY'

----------

HSBC RAISES AVIVA PRICE TARGET TO 420 (390) PENCE - 'HOLD'

----------

BERENBERG RAISES SMITH & NEPHEW PRICE TARGET TO 2,020 (1,985) PENCE - 'BUY'

----------

BARCLAYS RAISES SMITH & NEPHEW PRICE TARGET TO 1,800 (1,750) PENCE - 'OVERWEIGHT'

----------

SOCGEN RAISES BAE SYSTEMS PRICE TARGET TO 606 (580) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES ST JAMES'S PLACE TARGET TO 1,300 (1,250) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES SCHRODERS PRICE TARGET TO 2,925 (2,920) PENCE - 'SELL'

----------

BARCLAYS RAISES SCHRODERS PRICE TARGET TO 3,550 (3,430) PENCE - 'EQUAL WEIGHT'

----------

GOLDMAN SACHS RAISES UNILEVER PRICE TARGET TO 4,850 (4,800) PENCE - 'BUY'

----------

JEFFERIES RAISES UNILEVER PRICE TARGET TO 4,700 (4,550) PENCE - 'BUY'

----------

JEFFERIES RAISES ROYAL DUTCH SHELL PRICE TARGET TO 1,930 (1,890) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES ROYAL DUTCH SHELL B PRICE TARGET TO 2,100 (2,000) PENCE - 'BUY'

----------

RBC CUTS GLENCORE PRICE TARGET TO 360 (370) PENCE - 'OUTPERFORM'

----------

CREDIT SUISSE RAISES INFORMA PRICE TARGET TO 670 (650) PENCE - 'OUTPERFORM'

----------

FTSE 250

----------

SOCGEN RAISES MEGGITT TO 'HOLD' ('SELL') - TARGET 499 (418) PENCE

----------

GOLDMAN SACHS CUTS MEGGITT PRICE TARGET TO 436 (457) PENCE - 'NEUTRAL'

----------

BANK OF AMERICA CUTS MEGGITT PRICE TARGET TO 550 (560) PENCE - 'BUY'

----------

CITIGROUP RAISES COMPUTACENTER PRICE TARGET TO 2,985 (2,600) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES ELEMENTIS PRICE TARGET TO 148 (136) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES 888 HOLDINGS PRICE TARGET TO 460 (420) PENCE - 'BUY'

----------

BARCLAYS CUTS SSP GROUP PRICE TARGET TO 370 (420) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES CONVATEC PRICE TARGET TO 260 (250) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES WH SMITH PRICE TARGET TO 2,200 (1,535) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES SYNTHOMER PRICE TARGET TO 590 (515) PENCE - 'OUTPERFORM'

----------

LIBERUM CUTS TRAVIS PERKINS PRICE TARGET TO 1,791 (1,900) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

LIBERUM RAISES HSS HIRE PRICE TARGET TO 21 (12) PENCE - 'HOLD'

----------

BERENBERG RAISES CVS GROUP PRICE TARGET TO 2,400 (2,200) PENCE - 'BUY'

----------

RBC RAISES CVS GROUP PRICE TARGET TO 2,750 (2,400) PENCE - 'OUTPERFORM'

----------

HSBC RAISES KINGSPAN GROUP PRICE TARGET TO 79 (66) EUR - 'HOLD'

----------

BARCLAYS RAISES KERRY GROUP PRICE TARGET TO 131 (130) EUR - 'OVERWEIGHT'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
67891011121314

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.